Clinical Trial Applications: Filter, Search, and view applications
| # | Protocol No | Study Title | Investigator(s) & Site(s) | |
|---|---|---|---|---|
421. |
ECCT/15/03/01 | A phase III, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering A phase III, randomized, double-blind, active, controlled, multinational, multicentre, non-inferiority trial using Carbetocin room temperature stable (RTS) for the prevention of postpartum haemorrhage during the third stage of labour in women delivering vaginally. |
Principal Investigator(s) 1. Zahida Qureshi Site(s) in Kenya Kenyatta National Hospital |
View |
422. |
ECCT/15/02/03 | IVERMAL study Efficacy and safety of high-dose Ivermectin for reducing malaria transmission: A dose finding study |
Principal Investigator(s) 1. Menno Roderick Smit Site(s) in Kenya 1. Jaramogi Oginga Odinga Teaching and Referral Hospital (JOOTRH) (Kisumu county) 2. Kisumu District Hospital (KDH), (Kisumu county) 3. Siaya District Hospital (Siaya county) 4. Vihiga District Hospital (Vihiga county) |
View |
423. |
ECCT/15/01/03 | Simplifying ShangRing Circumcision for Men and Boys Simplifying the Shang Ring Technique for Circumcision of Men and Boys |
Principal Investigator(s) 1. Mark Barone Site(s) in Kenya 1. Homa Bay Level IV hospital (Homa Bay county) 2. Vipingo Health Centre (Kilifi county) |
View |
424. |
ECCT/15/01/02 | Study title An observational pilot study to characterize the immune response induced by the commercial Varicella Zoster Virus vaccine Zostavax® (Merck) in healthy adult females in Nairobi, Kenya. Clinical Phase IV |
Principal Investigator(s) 1. Prof Walter Jaoko Jaoko Site(s) in Kenya KAVI-INSTITUTE OF CLINICAL RESEARCH (KAVI-ICR) |
View |
425. |
ECCT/15/06/03 | DolutegrAvir With NRTIs as second-line treatment (DAWNING) A Phase 3b, randomised, open-label study of the antiviral activity and safety of dolutegravir compared to lopinavir/ritonavir both administered with dual nucleoside reverse transcriptase inhibitor therapy in HIV-1 infected adult subjects with treatment failure on first line therapy |
Principal Investigator(s) 1. Dr. Evans Inyangala Amukoye 2. Dr. Maricianah Atieno Onono Site(s) in Kenya 1. Center for Respiratory Diseases Research, CRDR, KEMRI, Nairobi (Nairobi City county) 2. KEMRI-Research Care and Training Program (RCTP), Family AIDS Care and Education Services (FACES), Lumumba health centre (Kisumu county) |
View |